Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/15/21
End: 01/31/22
Due: 01/31/23
Phase: N/A
Priority: Normal
Start: 05/24/17
End: 02/28/18
Due: 02/28/19
Phase: N/A
Priority: Normal
Start: 03/12/21
End: 09/10/21
Due: 09/10/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Multicenter Prospective Observational Study Evaluating the Management of Heart Failure | NCT05180370 | AstraZeneca Turkey | user2@example.com | None | 2021-03-15 | 2022-01-31 | 2023-01-31 | - | - | 2025-07-14 |
| Dapagliflozin in Type 2 Diabetes Patients, a Retrospective Cohort Study From Turkey | NCT03407196 | AstraZeneca Turkey | user2@example.com | None | 2017-05-24 | 2018-02-28 | 2019-02-28 | - | - | 2025-07-14 |
| A Study on Disease Awareness and Treatment Compliance of Heart Failure Patients | NCT05180396 | AstraZeneca Turkey | user2@example.com | None | 2021-03-12 | 2021-09-10 | 2022-09-10 | - | - | 2025-07-14 |